xCures
Company

Last deal

Amount

Convertible Note

Stage

01.12.2023

Date

10

all rounds

$13M

Total amount

General

About Company
xCures is an AI-based precision oncology platform that integrates cancer research and care.

Industry

Sector :

Subsector :

Keywords :

founded date

01.02.2018

Number of employees

Company Type

For Profit

Last funding type

Convertible Note

IPO status

Private

Description

xCures is a patient-centric AI-based virtual trial software that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. The platform coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. xCures uses artificial intelligence (A.I.) and predictive modeling to identify and rank the most promising treatment options for advanced cancer patients who are not responding to standard of care therapies. The platform captures RWE from patients being treated in various programs and studies, which is used to accelerate the development of new drugs, expand the approved uses of existing drugs, and demonstrate value for reimbursement. Patients pay with their data, and the platform provides them with a personalized list of top treatment options and information about how to access them.
Contacts

Phone number

Social url